Further, RNA-seq transcriptome analyses showed that AR-V7 potentiated several cancerous c-MYC downstream genes and suppressed a tumor suppressor Claudin 7 (Cldn7) that was upregulated by c-MYC overexpression. The gene discussed is CLDN7; the disease is neoplasm.